News

Survey on the added value of MSCA PhDs

Published on | 5 months ago

Programmes MSCA MSCA

The European Research Executive Agency (REA) of the European Commission is conducting a survey to gather (anonymous) feedback on the added value of MSCA PhDs, in comparison to other doctoral programmes.

The survey is addressed to principal investigators/supervisors as well as PhD researchers (PhD completed or ongoing) involved in MSCA and non-MSCA funded projects.

This feedback is highly valuable as it will help to improve the MSCA Doctoral Networks programme, which is managed by the REA. It will also feed into the European Commission’s wider policy reflections for the forthcoming period: promoting excellence in doctoral education and training is relevant to their strategic objectives for both the European Research Area (ERA) and the European Education Area (EEA), and contributes to the implementation of the European Strategy for Universities (here and here)             .

The survey can be accessed here and the Data Protection Notice here. Please note that it may take up to 1-2 minutes for the survey to load completely. The survey should take approximately 15 minutes to complete. The survey will remain open until 10 November 2024.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1581 articles available search in articles 

Testimonial

image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.